Mondelez International

NasdaqGS:MDLZ Stock Report

Mkt Cap: US$90.3b

We’ve recently updated our valuation analysis.

Mondelez International Valuation

Is MDLZ undervalued compared to its fair value, analyst forecasts and its price relative to the market?

Valuation Score

2/6

Valuation Score 2/6

  • Price-To-Earnings vs Peers

  • Price-To-Earnings vs Industry

  • Price-To-Earnings vs Fair Ratio

  • Below Fair Value

  • Significantly Below Fair Value

  • Analyst Forecast

Key Valuation Metric

Which metric is best to use when looking at relative valuation for MDLZ?

Other financial metrics that can be useful for relative valuation.

MDLZ key valuation metrics and ratios. From Price to Earnings, Price to Sales and Price to Book to Price to Earnings Growth Ratio, Enterprise Value and EBITDA.
Key Statistics
Enterprise Value/Revenue3.6x
Enterprise Value/EBITDA19.1x
PEG Ratio2.9x

Price to Earnings Ratio vs Peers

How does MDLZ's PE Ratio compare to its peers?

The above table shows the PE ratio for MDLZ vs its peers. Here we also display the market cap and forecasted growth for additional consideration.
CompanyPEEstimated GrowthMarket Cap
Peer Average28.3x
GIS General Mills
17x4.1%US$49.2b
HSY Hershey
30.1x5.3%US$47.7b
KHC Kraft Heinz
39.2x12.8%US$47.6b
HRL Hormel Foods
26.8x7.4%US$26.8b
MDLZ Mondelez International
28.8x9.8%US$90.3b

Price-To-Earnings vs Peers: MDLZ is expensive based on its Price-To-Earnings Ratio (28.8x) compared to the peer average (28.3x).


Price to Earnings Ratio vs Industry

How does MDLZ's PE Ratio compare vs other companies in the US Food Industry?

0 CompaniesPrice / EarningsEstimated GrowthMarket Cap
Industry Avg.n/a9.9%
n/an/an/a

Price-To-Earnings vs Industry: MDLZ is expensive based on its Price-To-Earnings Ratio (28.8x) compared to the US Food industry average (19.2x)


Price to Earnings Ratio vs Fair Ratio

What is MDLZ's PE Ratio compared to its Fair PE Ratio? This is the expected PE Ratio taking into account the company's forecast earnings growth, profit margins and other risk factors.

MDLZ PE Ratio vs Fair Ratio.
Fair Ratio
Current PE Ratio28.8x
Fair PE Ratio26.7x

Price-To-Earnings vs Fair Ratio: MDLZ is expensive based on its Price-To-Earnings Ratio (28.8x) compared to the estimated Fair Price-To-Earnings Ratio (26.7x).


Share Price vs Fair Value

What is the Fair Price of MDLZ when looking at its future cash flows? For this estimate we use a Discounted Cash Flow model.

Below Fair Value: MDLZ ($66.15) is trading below our estimate of fair value ($91.94)

Significantly Below Fair Value: MDLZ is trading below fair value by more than 20%.


Analyst Price Targets

What is the analyst 12-month forecast and do we have any statistical confidence in the consensus price target?

The above table shows the analyst MDLZ forecast and predictions for the stock price in 12 month’s time.
DateShare PriceAverage 1Y Price TargetDispersionHighLow1Y Actual priceAnalysts
CurrentUS$66.15
US$71.02
+7.4%
3.7%US$76.00US$66.00n/a23
Nov ’23US$61.87
US$69.45
+12.2%
5.1%US$75.00US$63.00n/a22
Oct ’23US$54.83
US$72.17
+31.6%
4.9%US$79.00US$64.00n/a22
Sep ’23US$61.97
US$72.42
+16.9%
4.8%US$79.00US$64.00n/a21
Aug ’23US$64.89
US$72.52
+11.8%
4.4%US$79.00US$63.00n/a21
Jul ’23US$63.34
US$72.73
+14.8%
4.2%US$78.00US$63.00n/a22
Jun ’23US$62.91
US$72.61
+15.4%
4.7%US$78.00US$63.00n/a23
May ’23US$64.48
US$72.05
+11.7%
5.1%US$78.00US$63.00n/a23
Apr ’23US$63.53
US$72.57
+14.2%
4.9%US$79.00US$63.00n/a22
Mar ’23US$64.34
US$72.98
+13.4%
5.7%US$79.00US$60.00n/a22
Feb ’23US$66.68
US$72.89
+9.3%
5.6%US$79.00US$60.00n/a22
Jan ’23US$66.31
US$70.36
+6.1%
4.9%US$75.00US$60.00n/a21
Dec ’22US$58.56
US$69.98
+19.5%
4.7%US$75.00US$60.00n/a21
Nov ’22US$60.91
US$69.96
+14.9%
5.2%US$75.00US$58.00US$61.8721
Oct ’22US$58.21
US$70.39
+20.9%
5.3%US$75.00US$58.00US$54.8321
Sep ’22US$62.33
US$70.39
+12.9%
5.3%US$75.00US$58.00US$61.9721
Aug ’22US$63.26
US$70.21
+11.0%
5.4%US$75.00US$58.00US$64.8921
Jul ’22US$62.47
US$68.36
+9.4%
5.3%US$74.00US$57.00US$63.3421
Jun ’22US$63.33
US$68.07
+7.5%
5.3%US$74.00US$57.00US$62.9121
May ’22US$60.81
US$67.77
+11.4%
5.2%US$74.00US$57.00US$64.4822
Apr ’22US$58.44
US$65.31
+11.8%
4.6%US$70.00US$57.00US$63.5322
Mar ’22US$53.66
US$65.12
+21.4%
5.2%US$70.00US$54.00US$64.3422
Feb ’22US$55.25
US$65.25
+18.1%
5.2%US$70.00US$54.00US$66.6823
Jan ’22US$58.47
US$63.95
+9.4%
5.3%US$70.00US$54.00US$66.3121
Dec ’21US$58.46
US$63.71
+9.0%
5.3%US$70.00US$54.00US$58.5621
Nov ’21US$53.12
US$63.14
+18.9%
5.2%US$69.00US$53.00US$60.9121

Analyst Forecast: Target price is less than 20% higher than the current share price.


Discover undervalued companies